Jenny Tosca Thom

Title: Innovator Spotlight: Jenny Tosca Thom

Introduction: Jenny Tosca Thom is an accomplished inventor based in Schlieren, Switzerland, known for her contributions to biopharmaceutical innovations. With expertise in developing targeted therapies, her work has the potential to make significant impacts in the medical field.

Latest Patents: Jenny holds a patent titled "Agonistic CD28 antigen binding molecules targeting Her2." This invention focuses on creating bispecific agonistic CD28 antigen binding molecules characterized by their monovalent binding to CD28. The patent encompasses methods for their production, pharmaceutical compositions containing these antibodies, and various applications for utilizing these innovative binding molecules in medical treatments.

Career Highlights: Currently, Jenny works at Hoffmann-La Roche Inc., a leading global healthcare company that specializes in pharmaceuticals and diagnostics. Her position there allows her to engage in cutting-edge research and development, enhancing her role as a pioneer in the field of biopharmaceuticals.

Collaborations: Throughout her career, Jenny has collaborated with notable professionals, including her coworker Stephan Gasser. Working alongside other experts in her field enhances the innovation process, leading to promising developments in therapies targeting critical health issues.

Conclusion: Jenny Tosca Thom exemplifies the spirit of innovation through her groundbreaking work in biopharmaceuticals. Her dedication to advancing healthcare via targeted therapies showcases her commitment to improving patient outcomes. With her patent contributions, she continues to be an influential figure in the research and development of innovative medical solutions.